In a promising advancement for cancer care, doctors at AIIMS Delhi have developed a new blood test that could assist in keeping track of whether a cervical treatment is working or if the disease ...

A simple blood test may help determine whether your cervical cancer is responding to treatment or whether it has relapsed, shows early research by doctors from the All India Institute of Medical ...

Researchers at AIIMS, Delhi have developed a simple blood test using droplet digital PCR (ddPCR) to track the effectiveness of cervical cancer treatment. Published in Scientific Reports ...

The prostate-specific antigen (PSA) test is a blood test which is currently used to check for prostate conditions including prostate cancer or an enlarged prostate. Routine PSA testing is not ...

A new at-home spit test for prostate cancer may be better than current blood tests, a new study shows. The simple saliva test has been developed by experts and works by analysing genetic variants in a ...

The prostate-specific antigen (PSA) test is a blood test which is currently used to check for prostate conditions including prostate cancer or an enlarged prostate. Routine PSA testing is not ...

The prostate-specific antigen (PSA) test is a blood test which is currently used to check for prostate conditions including prostate cancer or an enlarged prostate. Routine PSA testing is not ...

The prostate-specific antigen test is a blood test that is currently used to check for prostate conditions including prostate cancer or an enlarged prostate. Routine prostate-specific antigen testing ...

(PRNewsFoto/Quest Diagnostics Incorporated) The laboratory-developed test, named AD-Detect™ Abeta 42/40 and p-tau217 Evaluation, combines results of blood levels of amyloid beta (AB) 42/40 ...

This study is a significant step forward in the early detection of dementia. The idea of using a simple blood test to predict dementia risk years before symptoms appear is both exciting and ...

It's a single blood test that's starting to catch cancer evidence in the 57% of the body's sites that were previously unscreenable. On the heels of Colorectal Cancer Awareness Month in March comes ...